1887

Abstract

Ebola virus (EBOV), which belongs to the genus , causes a severe and often fatal infection in primates, including humans, whereas Reston virus (RESTV) only causes lethal disease in non-human primates. Two amino acids (aa) at positions 82 and 544 of the EBOV glycoprotein (GP) are involved in determining viral infectivity. However, it remains unclear how these two aa residues affect the infectivity of species in various hosts. Here we performed viral pseudotyping experiments with EBOV and RESTV GP derivatives in 10 cell lines from 9 mammalian species. We demonstrated that isoleucine at position 544/545 increases viral infectivity in all host species, whereas valine at position 82/83 modulates viral infectivity, depending on the viral and host species. Structural modelling suggested that the former residue affects viral fusion, whereas the latter residue influences the interaction with the viral entry receptor, Niemann–Pick C1.

Loading

Article metrics loading...

/content/journal/jgv/10.1099/jgv.0.000999
2018-02-01
2020-01-22
Loading full text...

Full text loading...

/deliver/fulltext/jgv/99/2/181.html?itemId=/content/journal/jgv/10.1099/jgv.0.000999&mimeType=html&fmt=ahah

References

  1. Kuhn JH, Andersen KG, Baize S, Bào Y, Bavari S et al. Nomenclature- and database-compatible names for the two Ebola virus variants that emerged in Guinea and the Democratic Republic of the Congo in 2014. Viruses 2014;6:4760–4799 [CrossRef][PubMed]
    [Google Scholar]
  2. Feldmann H, Geisbert TW. Ebola haemorrhagic fever. Lancet 2011;377:849–862 [CrossRef][PubMed]
    [Google Scholar]
  3. de La Vega MA, Stein D, Kobinger GP. Ebolavirus evolution: past and present. PLoS Pathog 2015;11:e1005221 [CrossRef][PubMed]
    [Google Scholar]
  4. Jayme SI, Field HE, de Jong C, Olival KJ, Marsh G et al. Molecular evidence of Ebola Reston virus infection in Philippine bats. Virol J 2015;12:107 [CrossRef][PubMed]
    [Google Scholar]
  5. Ogawa H, Miyamoto H, Nakayama E, Yoshida R, Nakamura I et al. Seroepidemiological prevalence of multiple species of filoviruses in fruit bats (Eidolon helvum) migrating in Africa. J Infect Dis 2015;212:S101–S108 [CrossRef][PubMed]
    [Google Scholar]
  6. Leroy EM, Kumulungui B, Pourrut X, Rouquet P, Hassanin A et al. Fruit bats as reservoirs of Ebola virus. Nature 2005;438:575–576 [CrossRef][PubMed]
    [Google Scholar]
  7. Ueda MT, Kurosaki Y, Izumi T, Nakano Y, Oloniniyi OK et al. Functional mutations in spike glycoprotein of Zaire ebolavirus associated with an increase in infection efficiency. Genes Cells 2017;22:148–159 [CrossRef][PubMed]
    [Google Scholar]
  8. Diehl WE, Lin AE, Grubaugh ND, Carvalho LM, Kim K et al. Ebola virus glycoprotein with increased infectivity dominated the 2013–2016 epidemic. Cell 2016;167:1088–1098 [CrossRef][PubMed]
    [Google Scholar]
  9. Urbanowicz RA, McClure CP, Sakuntabhai A, Sall AA, Kobinger G et al. Human adaptation of Ebola virus during the West African outbreak. Cell 2016;167:1079–1087 [CrossRef][PubMed]
    [Google Scholar]
  10. Hoffmann M, Crone L, Dietzel E, Paijo J, González-Hernández M et al. A polymorphism within the internal fusion loop of the Ebola virus glycoprotein modulates host cell entry. J Virol 2017;91:e00177-17 [CrossRef][PubMed]
    [Google Scholar]
  11. Wang MK, Lim SY, Lee SM, Cunningham JM. Biochemical basis for increased activity of Ebola glycoprotein in the 2013–16 epidemic. Cell Host Microbe 2017;21:367–375 [CrossRef][PubMed]
    [Google Scholar]
  12. Dietzel E, Schudt G, Krähling V, Matrosovich M, Becker S. Functional characterization of adaptive mutations during the West African Ebola virus outbreak. J Virol 2017;91:e01913-16 [CrossRef][PubMed]
    [Google Scholar]
  13. Ruedas JB, Ladner JT, Ettinger CR, Gummuluru S, Palacios G et al. Spontaneous mutation at amino acid 544 of the Ebola virus glycoprotein potentiates virus entry and selection in tissue culture. J Virol 2017;91:e00392-17 [CrossRef][PubMed]
    [Google Scholar]
  14. Tani H, Iha K, Shimojima M, Fukushi S, Taniguchi S et al. Analysis of Lujo virus cell entry using pseudotype vesicular stomatitis virus. J Virol 2014;88:7317–7330 [CrossRef][PubMed]
    [Google Scholar]
  15. Takada A, Watanabe S, Okazaki K, Kida H, Kawaoka Y. Infectivity-enhancing antibodies to Ebola virus glycoprotein. J Virol 2001;75:2324–2330 [CrossRef][PubMed]
    [Google Scholar]
  16. Gregory SM, Harada E, Liang B, Delos SE, White JM et al. Structure and function of the complete internal fusion loop from Ebolavirus glycoprotein 2. Proc Natl Acad Sci USA 2011;108:11211–11216 [CrossRef][PubMed]
    [Google Scholar]
  17. Gregory SM, Larsson P, Nelson EA, Kasson PM, White JM et al. Ebolavirus entry requires a compact hydrophobic fist at the tip of the fusion loop. J Virol 2014;88:6636–6649 [CrossRef][PubMed]
    [Google Scholar]
  18. Krishnan A, Miller EH, Herbert AS, Ng M, Ndungo E et al. Niemann-Pick C1 (NPC1)/NPC1-like1 chimeras define sequences critical for NPC1's function as a flovirus entry receptor. Viruses 2012;4:2471–2484 [CrossRef][PubMed]
    [Google Scholar]
  19. Côté M, Misasi J, Ren T, Bruchez A, Lee K et al. Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infection. Nature 2011;477:344–348 [CrossRef][PubMed]
    [Google Scholar]
  20. Carette JE, Raaben M, Wong AC, Herbert AS, Obernosterer G et al. Ebola virus entry requires the cholesterol transporter Niemann-Pick C1. Nature 2011;477:340–343 [CrossRef][PubMed]
    [Google Scholar]
  21. Wang H, Shi Y, Song J, Qi J, Lu G et al. Ebola viral glycoprotein bound to its endosomal receptor Niemann-Pick C1. Cell 2016;164:258–268 [CrossRef][PubMed]
    [Google Scholar]
  22. Maruyama J, Miyamoto H, Kajihara M, Ogawa H, Maeda K et al. Characterization of the envelope glycoprotein of a novel filovirus, lloviu virus. J Virol 2014;88:99–109 [CrossRef][PubMed]
    [Google Scholar]
  23. Ng M, Ndungo E, Kaczmarek ME, Herbert AS, Binger T et al. Filovirus receptor NPC1 contributes to species-specific patterns of ebolavirus susceptibility in bats. Elife 2015;4:e11785 [CrossRef][PubMed]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jgv/10.1099/jgv.0.000999
Loading
/content/journal/jgv/10.1099/jgv.0.000999
Loading

Data & Media loading...

Supplements

Supplementary File 1

PDF

Most cited articles

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error